Effect of iron supplementation during lactation on maternal iron status and oxidative stress
A randomized controlled trial
Bibliographic Data
| ID | 15537271 |
|---|---|
| Authors | Josh M Jorgensen (0000-0001-8299-2530, University of California, Davis, corresponding author), Zhenyu Yang (0000-0003-1388-2519, Chinese Center For Disease Control and Prevention), Bo Lönnerdal (0000-0002-3459-2484, University of California, Davis), Caroline J Chantry (0000-0002-1437-317X, University of California Davis Medical Center), Kathryn G Dewey (0000-0002-4185-3451, University of California, Davis) |
| Year | 2016 |
| Volume | 13 |
| Issue | 4 |
| Publication date | 2016-11-29 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Maternal and Child Nutrition (JOURNAL) |
| Journal identifiers | ISSN: 1740-8695 • E-ISSN: 1740-8709 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/mcn.12394 |
| PMID | 27896921 |
| OpenAlex | W2558839097 |
| Language | EN |
| Citations received | 1 |
| References cited | 6 |
We examined the effect of iron-containing prenatal vitamin-mineral supplements taken postpartum on biomarkers of iron status and oxidative stress. Lactating women (n = 114) were randomly assigned to consume daily one iron-free prenatal vitamin-mineral supplement plus either 27 mg of iron or placebo for approximately 3.5 months. The placebo group took the tablets between meals, while those given iron took the tablets either with (Fe-W) or between meals (Fe-B). Blood and urine samples were collected before and after the supplementation period to analyze hemoglobin (Hb), ferritin, hepcidin, transferrin saturation (TfSat), total plasma iron, and biomarkers of oxidative stress (isoprostane and 8-hydroxy-2-deoxyguanosine (8-OHdG)) and inflammation (C-reactive protein (CRP) and alpha-1-acid glycoprotein (AGP)). There was a trend toward a greater change in Hb among women in the Fe-B group compared to placebo (+2.5 vs. -3.7 g/L, respectively, p = 0.063). When the iron groups were combined, there was a greater change in Hb (+1.4 g/L) compared to placebo (p = 0.010). There were trends toward greater changes in TfSat (p = 0.087) and total plasma iron (p = 0.065) in the iron groups compared to placebo, yet no significant differences between the three groups in change in hepcidin (p = 0.291), isoprostane (p = 0.319), or 8-OHdG (p = 0.659), nor in change in ferritin among those with elevated CRP at baseline (60% of women; p = 0.946); among those without elevated CRP (40% of women), ferritin increased more in the iron groups compared to placebo (p = 0.001). Iron consumption during lactation moderately increased iron status, particularly among women without elevated CRP, and increased Hb, but did not significantly increase oxidative stress
Anemia · Biology · Ferritin · Hemoglobin · Hepcidin · Inflammation · Iron deficiency · Isoprostane · Lactation · Lipid peroxidation · Oxidative stress · Pathology · Placebo · Pregnancy · Serum ferritin · Transferrin saturation · Vitamin · Folate and B Vitamins Research · Hemoglobinopathies and Related Disorders · Iron Metabolism and Disorders · Medicine · Endocrinology · Internal Medicine
Estimation of the Youden Index and its Associated Cutoff Point
Analysing controlled trials with baseline and follow up measurements
Validation of a self-administered diet history questionnaire using multiple diet records
Ancova versus change from baseline had more power in randomized studies and more bias in nonrandomized studies
Effect of iron supplementation during lactation on maternal iron status and oxidative stress
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,1 |
| Citation span | 2016 - 2016 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |